Clinical trial
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms
NCT01816256 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms
- Lead sponsor
- University Health Network, Toronto
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- March 11, 2019
- Enrollment
- 102 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia (et), myelofibrosis (mf), myeloproliferative neoplasms (mpn), polycythemia vera (pv)